FOURIER OLE: Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension

Sponsor
Amgen (Industry)
Overall Status
Completed
CT.gov ID
NCT02867813
Collaborator
(none)
5,037
198
1
66.7
25.4
0.4

Study Details

Study Description

Brief Summary

The primary clinical hypothesis is that long-term exposure of evolocumab will be safe and well tolerated in subjects with clinically evident atherosclerotic cardiovascular disease (CVD).

Condition or Disease Intervention/Treatment Phase
  • Biological: Evolocumab
Phase 3

Detailed Description

This is a multicenter, open-label extension study designed to assess the long-term safety of evolocumab in subjects who completed the FOURIER study,which is a randomized placebo-controlled study of evolocumab in subjects with clinically evident atherosclerotic CVD on stable effective statin therapy. Eligible subjects at sites participating in FOURIER OLE who have signed the FOURIER OLE informed consent may be enrolled at the completion of FOURIER study.

Study Design

Study Type:
Interventional
Actual Enrollment :
5037 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Multicenter, Open-label, Single-arm, Extension Study to Assess Long-term Safety of Evolocumab Therapy in Patients With Clinically Evident Cardiovascular Disease
Actual Study Start Date :
Sep 2, 2016
Actual Primary Completion Date :
Mar 24, 2022
Actual Study Completion Date :
Mar 24, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: evolocumab (AMG 145)

All subjects are randomized to a single arm and will receive evolocumab 140mg every two weeks (Q2W) or 420mg monthly (QM) according to subject's preference.

Biological: Evolocumab
subjects will receive evolocumab 140 mg every 2 weeks (Q2W) or 420 mg monthly (QM), according to the subject's preference.

Outcome Measures

Primary Outcome Measures

  1. Subject incidence of adverse events [5 years]

Secondary Outcome Measures

  1. Percent change of LDL-C from baseline at each scheduled visit [5 years]

  2. Achieve an LDL-C < 40 mg/dL (1.03 mmol/L) at each scheduled visit [5 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subject has provided informed consent before initiation of any study-specific activities/procedures

  • Subject has completed FOURIER (Study 20110118) while still receiving assigned investigational product.

Exclusion Criteria:
  • Investigational product was permanently discontinued during FOURIER for any reason, including an adverse event or serious adverse event

  • Subject is currently receiving treatment in another investigational device or drug study, or ended treatment on another investigational device or drug study(ies) within less than 4 weeks. Other investigational procedures while participating in this study are excluded

  • Subject is not likely to be available to complete protocol-required study visits or procedures and/or to comply with required study procedures to the best of the subject's and investigator's knowledge

  • Subject has a history or evidence of any other clinically significant disorder, condition, or disease that, in the opinion of the investigator or Amgen physician, if consulted, would pose a risk to subject safety or interfere with the study evaluation, procedures, or completion

  • Subject has a known sensitivity to any of the active substances or excipients (eg, sodium acetate) to be administered during dosing

  • Female subject is pregnant or breastfeeding or is planning to become pregnant or planning to breastfeed during treatment with evolocumab and within 15 weeks after the end of treatment with evolocumab

  • Female subjects of childbearing potential who are not willing to use an acceptable method(s) of effective birth control during treatment with evolocumab and for an additional 15 weeks after the end of treatment with evolocumab are excluded

Contacts and Locations

Locations

Site City State Country Postal Code
1 Research Site Birmingham Alabama United States 35294
2 Research Site Huntsville Alabama United States 35801
3 Research Site Phoenix Arizona United States 85018
4 Research Site Banning California United States 92220
5 Research Site Long Beach California United States 90807
6 Research Site Oceanside California United States 92056
7 Research Site Oxnard California United States 93030
8 Research Site Palm Springs California United States 92262
9 Research Site Roseville California United States 95661
10 Research Site San Diego California United States 92161
11 Research Site San Pedro California United States 90732
12 Research Site Tarzana California United States 91356
13 Research Site Torrance California United States 90502
14 Research Site Valley Village California United States 91607
15 Research Site Aurora Colorado United States 80012
16 Research Site Colorado Springs Colorado United States 80909
17 Research Site Denver Colorado United States 80218
18 Research Site Littleton Colorado United States 80120
19 Research Site Boynton Beach Florida United States 33472
20 Research Site Clearwater Florida United States 33756
21 Research Site Crystal River Florida United States 34429
22 Research Site Daytona Beach Florida United States 32117
23 Research Site Hollywood Florida United States 33021
24 Research Site Hollywood Florida United States 33024
25 Research Site Jacksonville Florida United States 32216
26 Research Site Largo Florida United States 33777
27 Research Site Miami Florida United States 33173
28 Research Site New Port Richey Florida United States 34653
29 Research Site Pensacola Florida United States 32501
30 Research Site Ponte Vedra Beach Florida United States 32081
31 Research Site Port Charlotte Florida United States 33952
32 Research Site Saint Petersburg Florida United States 33713
33 Research Site Sarasota Florida United States 34232
34 Research Site Sarasota Florida United States 34239
35 Research Site Athens Georgia United States 30606
36 Research Site Atlanta Georgia United States 30342
37 Research Site Augusta Georgia United States 30909
38 Research Site Dunwoody Georgia United States 30338
39 Research Site Gainesville Georgia United States 30501
40 Research Site Savannah Georgia United States 31406
41 Research Site Suwanee Georgia United States 30024
42 Research Site Coeur d'Alene Idaho United States 83814
43 Research Site Meridian Idaho United States 83642
44 Research Site Addison Illinois United States 60101
45 Research Site Belleville Illinois United States 62220
46 Research Site Chicago Illinois United States 60616
47 Research Site Jerseyville Illinois United States 62052
48 Research Site Evansville Indiana United States 47714
49 Research Site Munster Indiana United States 46321
50 Research Site Iowa City Iowa United States 52242
51 Research Site Waterloo Iowa United States 50702
52 Research Site Kansas City Kansas United States 66160
53 Research Site Wichita Kansas United States 67203
54 Research Site Lexington Kentucky United States 40503
55 Research Site Hammond Louisiana United States 70403
56 Research Site Metairie Louisiana United States 70006
57 Research Site Monroe Louisiana United States 71201
58 Research Site Natchitoches Louisiana United States 71457
59 Research Site Slidell Louisiana United States 70458
60 Research Site Auburn Maine United States 04210
61 Research Site Bangor Maine United States 04401
62 Research Site Biddeford Maine United States 04005
63 Research Site Baltimore Maryland United States 21204
64 Research Site Columbia Maryland United States 21044
65 Research Site Salisbury Maryland United States 21804
66 Research Site Haverhill Massachusetts United States 01830
67 Research Site Newton Massachusetts United States 02459
68 Research Site Grandville Michigan United States 49418
69 Research Site Lansing Michigan United States 48912
70 Research Site Muskegon Michigan United States 49444
71 Research Site Saginaw Michigan United States 48601
72 Research Site Saint Cloud Minnesota United States 56303
73 Research Site Saint Paul Minnesota United States 55102
74 Research Site Tupelo Mississippi United States 38801
75 Research Site Kansas City Missouri United States 64128
76 Research Site Saint Louis Missouri United States 63128
77 Research Site Kalispell Montana United States 59901
78 Research Site Lincoln Nebraska United States 68506
79 Research Site Las Vegas Nevada United States 89148
80 Research Site Voorhees New Jersey United States 08043
81 Research Site Brooklyn New York United States 11206
82 Research Site Cortlandt Manor New York United States 10567
83 Research Site New Hyde Park New York United States 11042
84 Research Site New Windsor New York United States 12553
85 Research Site New York New York United States 10029
86 Research Site Rochester New York United States 14609
87 Research Site West Seneca New York United States 14224
88 Research Site Williamsville New York United States 14221
89 Research Site Calabash North Carolina United States 28467
90 Research Site Charlotte North Carolina United States 28204
91 Research Site Greensboro North Carolina United States 27408
92 Research Site Hickory North Carolina United States 28601
93 Research Site High Point North Carolina United States 27262
94 Research Site Mooresville North Carolina United States 28117
95 Research Site Statesville North Carolina United States 28625
96 Research Site Tabor City North Carolina United States 28463
97 Research Site Wilmington North Carolina United States 28401
98 Research Site Winston-Salem North Carolina United States 27103
99 Research Site Fargo North Dakota United States 58122
100 Research Site Canton Ohio United States 44710
101 Research Site Cincinnati Ohio United States 45219
102 Research Site Columbus Ohio United States 43201
103 Research Site Columbus Ohio United States 43215
104 Research Site Dayton Ohio United States 45414
105 Research Site Elyria Ohio United States 44035
106 Research Site Marion Ohio United States 43302
107 Research Site Sandusky Ohio United States 44870
108 Research Site Springfield Ohio United States 45505
109 Research Site Toledo Ohio United States 43615
110 Research Site Willoughby Ohio United States 44094
111 Research Site Pryor Oklahoma United States 74361
112 Research Site Tulsa Oklahoma United States 74133
113 Research Site Portland Oregon United States 97225
114 Research Site Camp Hill Pennsylvania United States 17011
115 Research Site Chambersburg Pennsylvania United States 17201
116 Research Site Philadelphia Pennsylvania United States 19152
117 Research Site Pittsburgh Pennsylvania United States 15206
118 Research Site Pawtucket Rhode Island United States 02860
119 Research Site Charleston South Carolina United States 29407
120 Research Site Indian Land South Carolina United States 29707
121 Research Site Moncks Corner South Carolina United States 29461
122 Research Site North Myrtle Beach South Carolina United States 29582
123 Research Site Rapid City South Dakota United States 57701
124 Research Site Germantown Tennessee United States 38138
125 Research Site Memphis Tennessee United States 38104
126 Research Site Nashville Tennessee United States 37203
127 Research Site Tullahoma Tennessee United States 37388
128 Research Site Austin Texas United States 78758
129 Research Site Houston Texas United States 77025
130 Research Site Houston Texas United States 77030
131 Research Site Kerrville Texas United States 78028
132 Research Site Plano Texas United States 75023
133 Research Site Plano Texas United States 75024
134 Research Site San Antonio Texas United States 78229
135 Research Site Wichita Falls Texas United States 76301
136 Research Site Layton Utah United States 84041
137 Research Site West Jordan Utah United States 84088
138 Research Site Burke Virginia United States 22015
139 Research Site Falls Church Virginia United States 22042
140 Research Site Richmond Virginia United States 23294
141 Research Site Suffolk Virginia United States 23435
142 Research Site Federal Way Washington United States 98003
143 Research Site Seattle Washington United States 98195
144 Research Site Green Bay Wisconsin United States 54301
145 Research Site Brno Czechia 603 00
146 Research Site Brno Czechia 625 00
147 Research Site Brno Czechia 638 00
148 Research Site Jihlava Czechia 586 33
149 Research Site Liberec Czechia 460 63
150 Research Site Mohelnice Czechia 789 85
151 Research Site Ostrava-Dubina Czechia 700 30
152 Research Site Ostrava Czechia 728 80
153 Research Site Praha 2 Czechia 128 08
154 Research Site Prerov Czechia 750 02
155 Research Site Pribram VIII Czechia 261 01
156 Research Site Znojmo Czechia 669 02
157 Research Site Bekescsaba Hungary 5600
158 Research Site Miskolc Hungary 3529
159 Research Site Nyiregyhaza Hungary 4400
160 Research Site Bielsko-Biala Poland 43-316
161 Research Site Bydgoszcz Poland 85-094
162 Research Site Gdansk Poland 80-542
163 Research Site Gdynia Poland 81-402
164 Research Site Gdynia Poland 81-472
165 Research Site Gizycko Poland 11-500
166 Research Site Katowice Poland 40-084
167 Research Site Kielce Poland 25-020
168 Research Site Krakow Poland 30-082
169 Research Site Krakow Poland 31-202
170 Research Site Krakow Poland 31-216
171 Research Site Lodz Poland 91-347
172 Research Site Lublin Poland 20-857
173 Research Site Nysa Poland 48-300
174 Research Site Olsztyn Poland 10-010
175 Research Site Plock Poland 09-402
176 Research Site Poznan Poland 61-853
177 Research Site Pszczyna Poland 43-200
178 Research Site Pulawy Poland 24-100
179 Research Site Ruda Slaska Poland 41-709
180 Research Site Skierniewice Poland 96-100
181 Research Site Staszow Poland 28-200
182 Research Site Swidnik Poland 21-040
183 Research Site Tarnow Poland 33-100
184 Research Site Torun Poland 87-100
185 Research Site Warszawa Poland 02-097
186 Research Site Warszawa Poland 02-507
187 Research Site Warszawa Poland 04-628
188 Research Site Wloclawek Poland 87-800
189 Research Site Wroclaw Poland 50-349
190 Research Site Zamosc Poland 22-400
191 Research Site Moscow Russian Federation 129090
192 Research Site Saint-Petersburg Russian Federation 192289
193 Research Site Saint-Petersburg Russian Federation 197022
194 Research Site Saint-Petersburg Russian Federation 199106
195 Research Site Saratov Russian Federation 410054
196 Research Site Kosice Slovakia 040 22
197 Research Site Svidnik Slovakia 089 01
198 Research Site Zaporizhzhya Ukraine 69600

Sponsors and Collaborators

  • Amgen

Investigators

  • Study Director: MD, Amgen

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Amgen
ClinicalTrials.gov Identifier:
NCT02867813
Other Study ID Numbers:
  • 20130295
  • 2015-004780-36
First Posted:
Aug 16, 2016
Last Update Posted:
Apr 5, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Keywords provided by Amgen
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 5, 2022